Journal
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE
Volume 35, Issue 5, Pages 951-960Publisher
AMER BOARD FAMILY MEDICINE
DOI: 10.3122/jabfm.2022.AP.210514
Keywords
Directly Observed Therapy; Linear Models; Stigmatization; Telemedicine; Tuberculosis
Categories
Ask authors/readers for more resources
This study investigates the impact of video directly observed therapy (VDOT) on stigma levels in tuberculosis patients. The findings indicate that patients receiving VDOT experience lower levels of stigma compared to those receiving homecare directly observed therapy (DOT). The study also identifies VDOT and male gender as independent factors associated with higher total stigma scores.
Introduction: To investigate the effect of video directly observed therapy (VDOT) on stigma levels inMethods: Thirty TB patients (36.5%) receiving directly observed therapy (DOT) and 52 receiving VDOT (63.4%) between 15.08.2021 and 15.10.2021 in Samsun, Turkey, were included in this study (n = 82). All the participants completed the Stigma Scale in Patients with Tuberculosis (SSTB), and their demographic and disease characteristics were investigated.Results: The mean age of the participants was 50.0 +/- 17.8 years, 64 were married (78.8%), and 38 were women (46.3%) in the study group. Sixty patients had pulmonary TB (73.1%), and duration of disease was less than 6 months in 64 (82.9) patients. The mean SSTB score was 84.2 +/- 12.3, the DOT group exhibiting higher SSTB scores then the VDOT group (t = 2.524, P = .006). The VDOT group had lower mean SSTB subdimension mean scores (perceived stigma, self-perception internalized stigma, and family/friend relations) (P <.05). Linear regression models identified VDOT and male gender as independent factors for increased total SSTB scores (P < .05). VDOT was also identified as an independent factor for total SSTB subdimension scores in the linear regression models (P <.05). Conclusion: Our results confirm that TB patients who receive VDOT has less stigmata compared with homecare DOT. ( J Am Board Fam Med 2022;35:951-960.)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available